Skip to main content
SpringerLink
Log in

Primary Prevention of Allergic Sensitisation

How Might it Work?

  • Leading Article
  • Published:
BioDrugs Aims and scope Submit manuscript

Abstract

Allergic diseases, particularly allergic asthma, are among the most frequent disorders seen in paediatric practice and clinic. Epidemiological data as well as recent immunological studies have largely contributed to the identification of risk factors eventually leading to the clinical manifestation of allergy. Various strategies of primary prevention are being developed and most of them include avoidance of identified or presumed risk factors.

Another promising field of research investigates pharmacological approaches in the prevention of allergy, and drugs have been identified which interfere with the pathophysiological pathways. It seems likely that they may play an important role in future primary prevention strategies especially targeting infants at high risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Holt PG, Sly PD. Allergic respiratory disease: strategic targets for primary prevention during childhood. Thorax 1997; 52: 1–4

    Article  PubMed  CAS  Google Scholar 

  2. Leung DYM, Geha RS. Regulation of the human IgE antibody response. Intern Rev Immunol 1987; 2: 75–91

    Article  CAS  Google Scholar 

  3. Corrigan CJ, Hartnell A, Kay AB. T lymphocyte activation in acute severe asthma. Lancet 1988; I: 1129–32

    Article  Google Scholar 

  4. Walker C, Kaegi MK, Braun P, et al. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935–42

    Article  PubMed  CAS  Google Scholar 

  5. Miles EA, Warner JA, Lane AC, et al. Altered T lymphocyte phenotype at birth in babies born to atopic parents. Pediatr Allergy Immunol 1994 Nov; 5(4): 202–8

    Article  PubMed  CAS  Google Scholar 

  6. Holt PG. Immunoprophylaxis of atopy: light at the end of the tunnel? Immunol Today 1994 Oct; 15(10): 484–9

    Article  PubMed  CAS  Google Scholar 

  7. Kondo N, Kobayashi Y, Shinoda S, et al. Cord blood lymphocyte responses to food antigens for the prediction of allergic disorders. Arch Dis Child 1992 Aug; 67(8): 1003–7

    Article  PubMed  CAS  Google Scholar 

  8. Tang MLK, Kemp AS, Thorburn J, et al. Reduced interferongamma secretion in neonates is associated with the subsequent development of atopy. Lancet 1994; 344: 983–5

    Article  PubMed  CAS  Google Scholar 

  9. Wahn U, Bergmann R, Kulig M, et al. The natural course of sensitisation and atopic disease in infancy and childhood. Pediatr Allergy Immunol 1997; 8(10 Suppl.): 16–20

    PubMed  CAS  Google Scholar 

  10. Holt PG. Infections and the development of allergy. Toxicol Lett 1996 Aug; 86(2–3): 205–10

    Article  PubMed  CAS  Google Scholar 

  11. Peat JK, Salome CM, Woolcock AJ. Longitudinal changes in atopy during a 4 year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren. J Allergy Clin Immunol 1990; 85: 65–74

    Article  PubMed  CAS  Google Scholar 

  12. Hattevig G, Kjellman B, Björksten B. Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol 1993; 4: 182–6

    Article  PubMed  CAS  Google Scholar 

  13. Bergmann R, Woodcock A. Whole population or high-risk group? Childhood asthma. Eur Resp J Suppl 1998 Jul; 27: 9s–12s

    CAS  Google Scholar 

  14. Hide DW. Early intervention for the prevention of atopic dermatitis. Pediatr Allergy Immunol 1997 Feb; 8(1): 7–10

    Article  PubMed  CAS  Google Scholar 

  15. Xu B, Pekkanen J, Jarvelin MR, et al. Maternal factors during pregnancy and the development of asthma among off spring [abstract]. Am J Resp Crit Care Med 157(3); Mar 1998: A11

    Google Scholar 

  16. Falth-Magnusson K, Kjellman N-IM. Allergy prevention by maternal elimination during late pregnancy — a five year follow-up of a randomized study. J Allergy Clin Immunol 1992; 89: 709–13

    Article  PubMed  CAS  Google Scholar 

  17. Wolfe SP. Prevention programmes- a dietetic minefield. Eur J Clin Nutr 1995 Sep; 49Suppl. 1: S92–9

    PubMed  Google Scholar 

  18. Kuehr J, Frischer T, Meinert R, et al. Mite allergen exposure is a risk for the incidence of specific sensitization. J Allergy Clin Immunol 1994; 94: 44–52

    Article  PubMed  CAS  Google Scholar 

  19. Peat JK, Tovey ER, Toelle BG, et al. House dust mite allergens: a major risk factor for childhood asthma in Australia. Am J Resp Crit Care Med 1996; 153: 141–6

    PubMed  CAS  Google Scholar 

  20. Warner AM, Björkstén B, Munir AKM, et al. Childhood asthma and exposure to indoor allergens: low mite levels are associated with sensitivity. Pediatr Allergy Immunol 1996; 7: 61–7

    Article  PubMed  CAS  Google Scholar 

  21. Sporik R, Holgate ST, Platts-Mills TAE, et al. Exposure to house-dust mite allergen (Der p 1) and the development of asthma in childhood: aprospective study. N Engl J Med 1990; 323: 502–7

    Article  PubMed  CAS  Google Scholar 

  22. Custovic A, Fletcher A, Pickering CA, et al. Domestic allergens in public places III: house dust mite, cat, dog and cockroach allergens in British hospitals. Clin Exp Allergy 1998 Jan; 28(1): 53–9

    Article  PubMed  CAS  Google Scholar 

  23. Weeks J, Oliver J, Birmingham K, et al. A combined approach to reduce mite allergen in the bedroom. Clin Exp Allergy 1995; 25: 1179–83

    Article  PubMed  CAS  Google Scholar 

  24. Marks GB, Tovey ER, Green W, et al. House-dust mite allergen avoidance: a randomized, controlled trial of surface chemical treatment and encasement of bedding. Clin Exp Allergy 1994; 24: 1078–83

    Article  PubMed  CAS  Google Scholar 

  25. McDonald LG, Tovey ER. The role of water temperature and laundry procedures in reducing house-dust mite populations and allergen content of bedding. J Allergy Clin Immunol 1992; 90: 599–608

    Article  PubMed  CAS  Google Scholar 

  26. Murray AB, Fergusson AC. Dust-free bedrooms in the treatment of asthmatic children with house-dust mite allergy: a controlled trial. Pediatrics 1983; 71: 418–22

    PubMed  CAS  Google Scholar 

  27. Wassenaar DPJ. Effectiveness of vacuum cleaning and wet cleaning in reducing house-dust mites, fungi and mite allergens in cotton carpet: a case study. Exp Appl Acarol 1988; 4: 53–62

    Article  PubMed  CAS  Google Scholar 

  28. Kuehr J, Frischer T, Karmaus W, et al. Natural variation in mite antigen density in house dust and relationship to residential factors. Clin Exp Allergy 1994; 24: 229–37

    Article  PubMed  CAS  Google Scholar 

  29. Warner JA, Little SA, Pollock I, et al. The influence of exposure to house-dust mite, cat pollen and fungal allergens in the home on primary sensitisation in asthma. Pediatr Allergy Immunol 1990; 1: 79–86

    Google Scholar 

  30. Sporik R, Ingram MJ, Price W, et al. Association of asthma with serum IgE and skin test reactivity to allergens among children living at high altitude: tickling the dragon’s breath. Am J Resp Crit Care Med 1995; 151: 1388–92

    PubMed  CAS  Google Scholar 

  31. Popp W, Rauscher H, Serti K, et al. Risk factors for sensitization to furred pets. Allergy 1990 Jan; 45(1): 75–9

    Article  PubMed  CAS  Google Scholar 

  32. Oshiba A, Hamelmann E, Bradley KL, et al. Pretreatment with allergen prevents immediate hypersensitivity and airway hyperresponsiveness. Am J Resp Crit Care Med 1996; 153: 102–9

    PubMed  CAS  Google Scholar 

  33. Wahn U, Lau S, Bergmann R, et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol 1997 Jun; 99(6 Pt 1): 763–9.

    Article  PubMed  CAS  Google Scholar 

  34. Becker A, Manfreda J, Watson W, et al. Risk factors for the development of asthma and other allergic disorders in high risk infants [abstract]. Am J Resp Crit Care Med 1998 Mar; 157(3): A 159

    Google Scholar 

  35. Cook DG, Strachan DP, Carey IM. Health effects of passive smoking. 9-Parental smoking and spirometric indices in children. Thorax 1998; 53: 884–93

    Article  PubMed  CAS  Google Scholar 

  36. Peat JK. Environmental tobacco smoke. In: Barnes P, Grunstein MM, Leff A et al., editors. Asthma. Philadelphia: Lippincott-Raven Publishers, 1997: 1177–92

    Google Scholar 

  37. Cook DG, Strachan DP. Health effects of passive smoking. 7-Parental smoking, bronchial reactivity and peak flow variability in children. Thorax 1998; 53: 295–301

    Article  PubMed  CAS  Google Scholar 

  38. Sigurs N, Hattevig G, Kjellman B. Maternal avoidance of eggs, cow’s milk, and fish during lactation: effect on allergic manifestations, skin-prick tests, and specific IgE antibodies in children at age 4 years. Pediatrics 1992 Apr; 89(4 Pt 2): 735–9

    PubMed  CAS  Google Scholar 

  39. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 1995 Jun; 95(6): 1179–90

    Article  PubMed  CAS  Google Scholar 

  40. Chandra RK. Five-year follow-up of high-risk infants with family history of allergy who were exclusively breast-fed or fed partial whey hydrolysate, soy, and conventional cow’s milk formulas. J Pediatr Gastroenterol Nutr 1997 Apr; 24(4): 380–8

    Article  PubMed  CAS  Google Scholar 

  41. Golding J, Emmett PM, Pogers IS. Eczema, asthma and allergy. Early Hum Dev 1997 Oct 29; 49Suppl.: S121–30

    Article  PubMed  Google Scholar 

  42. Wijst M, Dold S, Reitmeier P, et al. Does breast feeding prevent asthma and allergies? Results of the Munich asthma and allergy study. Monatsschr Kinderheilkd 1992 Oct; 140(10): 769–4

    Google Scholar 

  43. Rugo E, Wahl R, Wahn U. How allergenic are hypoallergenic infant formulae? Clin Exp Allergy 1992; 22: 635–9

    Article  PubMed  CAS  Google Scholar 

  44. Odelram H, Vanto T, Jacobsen L, et al. Whey hydrolysate compared with cow’s milk-based formula for weaning at about 6 months of age in high allergy-risk infants: effects on atopic disease and sensitization. Allergy 1996 Mar; 51(3): 192–5

    Article  PubMed  CAS  Google Scholar 

  45. Oldaeus G, Anjou K, Björksten B, et al. Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Arch Dis Child 1997; 77: 4–10

    Article  PubMed  CAS  Google Scholar 

  46. Hide DW, Matthews S, Tariq S, et al. Allergen avoidance in infancy and allergy 4 years of age. Allergy 1996; 51: 89–93

    PubMed  CAS  Google Scholar 

  47. von Mutius E, Schwartz J, Neas LM, et al. Serum lipoprotein A in childhood asthma [abstract]. Am J Resp Crit Care Med 1998 Mar; 157(3): All

    Google Scholar 

  48. Strannegard O, Cello J, Bjarnason R, et al. Association between pronounced IgA response in RSV bronchiolitis and development of allergic sensitization. Pediatr Allergy Immunol 1997 Feb; 8(1): 1–6

    Article  PubMed  CAS  Google Scholar 

  49. Martinez FD. Viral infections and the development of asthma. Am J Resp Crit Care Med 1995 May; 151(5): 1644–7

    PubMed  CAS  Google Scholar 

  50. Herz U, Gerhold K, Gruber C, et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998 Nov; 102(5): 867–74

    Article  PubMed  CAS  Google Scholar 

  51. Strachan DP, Harkins LS, Johnston ID, et al. Childhood antecedents of allergic sensitization in young British adults. J Allergy Clin Immunol 1997 Jan; 99(1 Pt 1): 6–12

    PubMed  CAS  Google Scholar 

  52. Martinez FD. Role of viral infections in the inception of asthma and allergies during childhood: could they be protective? Thorax 1994; 49: 1189–91

    Article  PubMed  CAS  Google Scholar 

  53. Cooper KD. New therapeutic approaches in atopic dermatitis. Clin Rev Allergy 1993; 11: 543–9

    PubMed  CAS  Google Scholar 

  54. Lock SH, Kay AB, Barnes NC. Double-blind, placebo-controlled study of cyclosporin A as a corticoid-sparing agent in corticosteroid-dependent asthma. Am J Resp Crit Care Med 1996; 153: 509–14

    PubMed  CAS  Google Scholar 

  55. Bissonnette EY, Enciso JA, Befus AD. Inhibition of tumour necrosis factor-alpha (TNF-alpha) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin Exp Immunol 1995; 102: 78–84

    Article  PubMed  CAS  Google Scholar 

  56. Rubinchik E, Norris A, Levi-Schaffer F. Modulations of histamine release from mast cells by interleukin-2 is affected by nedocromil sodium. Int J Immunopharmacol 1995; 17: 563–70

    Article  PubMed  CAS  Google Scholar 

  57. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: first results of ETAC. Early treatment of the atopic child. Pediatr Allergy Immunol 1998 Aug; 9: 116–24

    Article  Google Scholar 

  58. Eber E, Uhlig T, McMenamin C, et al. Leflunomide, a novel immunomodulating agent, prevents the development of allergic sensitization in an animal model of allergic asthma. Clin Exp Allergy 1998; 28: 376–84

    Article  PubMed  CAS  Google Scholar 

  59. Uhlig T, Cooper D, Eber E, et al. Effects of long-term oral treatment with leflunomide on allergic sensitization, lymphocyte activation, and airway inflammation in a rat model of asthma. Clin Exp Allergy 1998; 28: 758–64

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Allergy and Pulmonology, Margaritenhospital Schwäbisch Gmünd, Schwäbisch Gmünd, Germany

    Torsten Uhlig

  2. Respiratory and Allergic Disease Division, Department of Paediatrics, University of Graz, Graz, Austria

    Ernst Eber

  3. Division of Clinical Sciences, TVW Telethon Institute for Child Health Research, Perth, Western Australia, Australia

    Peter D. Sly

Authors
  1. Torsten Uhlig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ernst Eber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter D. Sly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Torsten Uhlig.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uhlig, T., Eber, E. & Sly, P.D. Primary Prevention of Allergic Sensitisation. BioDrugs 12, 13–18 (1999). https://doi.org/10.2165/00063030-199912010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00063030-199912010-00002

Keywords

Search

Navigation